Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Current Taxes (2017 - 2018)

Corcept Therapeutics (CORT) has disclosed Current Taxes for 2 consecutive years, with $1.6 million as the latest value for Q3 2018.

  • Quarterly Current Taxes changed N/A to $1.6 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Sep 2018, changed N/A year-over-year, with the annual reading at $66000.0 for FY2017, N/A changed from the prior year.
  • Current Taxes hit $1.6 million in Q3 2018 for Corcept Therapeutics, up from $687000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $1.6 million in Q3 2018 to a low of $66000.0 in Q4 2017.